MedPath

Evaluation of Radioiodine Scintigraphy (123I) with SPECT/CT prepared with rhTSH, for the Detection of Distant Metastasis 5-years after thyroidectomy in patients with differentiated thyroid cancer

Conditions
Neoplasms
Registration Number
KCT0004216
Lead Sponsor
Sanofi-Aventis Korea
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
421
Inclusion Criteria

20- 70 year old
male and female patients
total thyroidectomy
Total thyroidectomy performed at Gangnam Severance Hospital between January 2010 and December 2011
visiting the outpatient clinic for 5-year postoperative follow-up and who were scanned with SPECT/CT and treated with rhTSH between September 2016 and September 2016

Exclusion Criteria

contraindication to RAI treatment
patients with no thyroglobulin level measured before and afer treatment
pregnant and lactating women

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
distant metastasis
Secondary Outcome Measures
NameTimeMethod
thyroglobulin
© Copyright 2025. All Rights Reserved by MedPath